Ryan Fiehler

Ryan works from the Cambridge UK site, and he has been with F-star for a little over 8 years.

Ryan is a co-lead of the Discovery Department, where they design and build the next drugs to enter the F-star pipeline. They are a growing team that incorporates the principles of directed evolution to produce our bispecific antibodies called mAb2. Most of the work focuses on testing large numbers of molecules to find the ones that have the specific qualities that we are after, i.e. stimulating immune cells.